Navigenics Cuts Price of Screening Service 60 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Consumer genomics firm Navigenics has cut the price of its comprehensive genetic screening service by 60 percent, from $2,500 to $999, the firm announced on its blog, The Navigator.

A thousand dollars buys customers a year subscription to Navigenics' Health Compass testing services, which includes genetic risk data for 28 diseases and conditions; an hour-long session with a genetic counselor; and updates to risk scores as new gene associations and diseases are added to the service.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.